Article 31 Jan 2024 When Does A Drug Label Induce Infringement Under 35 U.S.C. § 271(e)(2) Of A Patent Not Claiming An Indication Or Method Of Use? United States Healthcare
Article 15 Jan 2024 USPTO Releases Examiner Guidance For The Amgen Enablement Decision United States Healthcare
Article 27 Dec 2023 In Patent Eligibility It's The Claim That Is The Name Of The Game* United States IP
Article 22 Nov 2023 Sisvel – PTAB Guidance On A Proposed Amendment In An IPR Is Not Binding On The PTAB United States IP
Article 15 Nov 2023 FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice United States Commercial
Article 23 Oct 2023 FDA Announces Formation Of A New Digital Health Advisory Committee United States Healthcare
Article 18 Sep 2023 In Re Cellect – ODP Defense Does Not Impact The Expiration Date Of A Patent With Both PTA And PTE In The Absence Of A Terminal Disclaimer United States IP